You are currently viewing a new version of our website. To view the old version click .

460 Results Found

  • Review
  • Open Access
259 Citations
17,097 Views
21 Pages

Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature

  • Michael W. Peck,
  • Theresa J. Smith,
  • Fabrizio Anniballi,
  • John W. Austin,
  • Luca Bano,
  • Marite Bradshaw,
  • Paula Cuervo,
  • Luisa W. Cheng,
  • Yagmur Derman and
  • Brigitte G. Dorner
  • + 15 authors

18 January 2017

Botulinum neurotoxins are diverse proteins. They are currently represented by at least seven serotypes and more than 40 subtypes. New clostridial strains that produce novel neurotoxin variants are being identified with increasing frequency, which pre...

  • Review
  • Open Access
19 Citations
10,748 Views
19 Pages

24 May 2022

Clostridium botulinum and Clostridium tetani are Gram-positive, spore-forming, and anaerobic bacteria that produce the most potent neurotoxins, botulinum toxin (BoNT) and tetanus toxin (TeNT), responsible for flaccid and spastic paralysis, respective...

  • Article
  • Open Access
21 Citations
8,445 Views
12 Pages

Botulinum Neurotoxin Serotypes Detected by Electrochemical Impedance Spectroscopy

  • Alison C. Savage,
  • Nicholas Buckley,
  • Jennifer Halliwell and
  • Christopher Gwenin

6 May 2015

Botulinum neurotoxin is one of the deadliest biological toxins known to mankind and is able to cause the debilitating disease botulism. The rapid detection of the different serotypes of botulinum neurotoxin is essential for both diagnosis of botulism...

  • Article
  • Open Access
10 Citations
2,307 Views
13 Pages

Surface Acoustic Wave Immunosensor for Detection of Botulinum Neurotoxin

  • Michał Grabka,
  • Krzysztof Jasek and
  • Zygfryd Witkiewicz

6 September 2023

A Love-type acoustic wave sensor (AT-cut quartz substrate, SiO2 guiding layer) with a center frequency of approximately 120 MHz was used to detect a simulant of pathogenic botulinum neurotoxin type A—recombinant of BoNT-A light chain—in l...

  • Review
  • Open Access
65 Citations
12,372 Views
18 Pages

11 January 2019

Botulinum neurotoxins (BoNTs) are the most lethal toxins among all bacterial, animal, plant and chemical poisonous compounds. Although a great effort has been made to understand their mode of action, some questions are still open. Why, and for what b...

  • Review
  • Open Access
49 Citations
13,820 Views
8 Pages

10 April 2022

Botulinum neurotoxin injection for treating glabellar frown lines is a commonly used method; however, side effects, such as ptosis and samurai eyebrow, have been reported due to a lack of comprehensive anatomical knowledge. The anatomical factors imp...

  • Article
  • Open Access
1 Citations
1,990 Views
15 Pages

Background: Botulinum neurotoxin is widely regarded as a “wonder medicine” due to its therapeutic efficacy in treating a variety of conditions. While it is traditionally classified as a neurotoxin, it is arguably more appropriate to refer...

  • Review
  • Open Access
8 Citations
8,732 Views
22 Pages

Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia

  • Winnie Yeung,
  • Amanda L. Richards and
  • Daniel Novakovic

1 December 2022

Laryngeal dystonia (LD), or spasmodic dysphonia (SD), is a chronic, task-specific, focal movement disorder affecting the larynx. It interferes primarily with the essential functions of phonation and speech. LD affects patients’ ability to commu...

  • Review
  • Open Access
7 Citations
3,184 Views
10 Pages

Voice Tremor and Botulinum Neurotoxin Therapy: A Contemporary Review

  • David P. Newland,
  • Daniel Novakovic and
  • Amanda L. Richards

9 November 2022

Voice tremor is a common, yet debilitating symptom for patients suffering from a number of tremor-associated disorders. The key to targeting effective treatments for voice tremor requires a fundamental understanding of the pathophysiology that underp...

  • Review
  • Open Access
12 Citations
4,885 Views
13 Pages

19 March 2021

Parkinson’s disease is the most common age-related motoric neurodegenerative disease. In addition to the cardinal motor symptoms of tremor, rigidity, bradykinesia, and postural instability, there are numerous non-motor symptoms as well. Among the non...

  • Opinion
  • Open Access
12 Citations
7,139 Views
14 Pages

1 August 2018

Botulinum neurotoxins (BoNTs) rank amongst the most potent toxins known. The factors responsible for the emergence of the many known and yet unknown BoNT variants remain elusive. It also remains unclear why anaerobic bacteria that are widely distribu...

  • Review
  • Open Access
31 Citations
21,204 Views
7 Pages

15 May 2022

Botulinum neurotoxin injection surrounding the nose area is frequently used in aesthetic settings. However, there is a shortage of thorough anatomical understanding that makes it difficult to treat wrinkles in the nose area. In this study, the anatom...

  • Article
  • Open Access
11 Citations
4,853 Views
15 Pages

Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody

  • Federico Fabris,
  • Petra Šoštarić,
  • Ivica Matak,
  • Thomas Binz,
  • Anna Toffan,
  • Morena Simonato,
  • Cesare Montecucco,
  • Marco Pirazzini and
  • Ornella Rossetto

Tetanus and Botulinum type B neurotoxins are bacterial metalloproteases that specifically cleave the vesicle-associated membrane protein VAMP at an identical peptide bond, resulting in inhibition of neuroexocytosis. The minute amounts of these neurot...

  • Review
  • Open Access
48 Citations
13,045 Views
27 Pages

28 December 2017

Injections of botulinum neurotoxins (BoNTs) are prescribed by clinicians for a variety of disorders that cause over-activity of muscles; glands; pain and other structures. Accurately targeting the structure for injection is one of the principle goals...

  • Article
  • Open Access
14 Citations
8,020 Views
14 Pages

Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody

  • Yağmur Derman,
  • Katja Selby,
  • Sebastian Miethe,
  • André Frenzel,
  • Yvonne Liu,
  • Christine Rasetti-Escargueil,
  • Arnaud Avril,
  • Thibaut Pelat,
  • Remi Urbain and
  • Alexandre Fontayne
  • + 5 authors

12 September 2016

Botulinum neurotoxins (BoNTs) cause botulism and are the deadliest naturally-occurring substances known to humans. BoNTs have been classified as one of the category A agents by the Centers for Disease Control and Prevention, indicating their potentia...

  • Review
  • Open Access
3,758 Views
20 Pages

Research Progress on the Detection Methods of Botulinum Neurotoxin

  • Shuo Wang,
  • Huajie Zhang,
  • Yanhua Xue,
  • Yingchao Yang and
  • Liyong Yuan

8 September 2025

Botulinum neurotoxins (BoNTs), produced by the anaerobic spore-forming bacterium Clostridium botulinum, are among the most potent known biological toxins. BoNTs cause lethal botulism via contaminated food, wound infections, or infant intestinal colon...

  • Article
  • Open Access
19 Citations
8,117 Views
12 Pages

Botulinum Neurotoxin A Complex Recognizes Host Carbohydrates through Its Hemagglutinin Component

  • Guorui Yao,
  • Kwangkook Lee,
  • Shenyan Gu,
  • Kwok-Ho Lam and
  • Rongsheng Jin

12 February 2014

Botulinum neurotoxins (BoNTs) are potent bacterial toxins. The high oral toxicity of BoNTs is largely attributed to the progenitor toxin complex (PTC), which is assembled from BoNT and nontoxic neurotoxin-associated proteins (NAPs) that are produced...

  • Review
  • Open Access
71 Citations
24,508 Views
30 Pages

7 January 2010

Sensitive and rapid detection of botulinum neurotoxins (BoNTs), the most poisonous substances known to date, is essential for studies of medical applications of BoNTs and detection of poisoned food, as well as for response to potential bioterrorist t...

  • Article
  • Open Access
1,276 Views
9 Pages

31 July 2025

While surgical procedure has been considered as the golden standard treatment for spasmodic entropion, Botulinum Neurotoxin A can be indicated in the treatment of spasmodic entropion for fragile elderly patients. This retrospective cohort study inclu...

  • Review
  • Open Access
40 Citations
29,316 Views
7 Pages

10 December 2022

The platysma muscle is a thin superficial muscle that covers the entire neck and lower part of the face. The platysma muscle is the primary target muscle for botulinum neurotoxin injection therapy aimed at treating platysmal band and lower facial lif...

  • Article
  • Open Access
32 Citations
8,367 Views
20 Pages

17 May 2016

Botulinum neurotoxins (BoNTs) exhibit extraordinary potency due to their exquisite neurospecificity, which is achieved by dual binding to complex polysialo-gangliosides and synaptic vesicle proteins. The luminal domain 4 (LD4) of the three synaptic v...

  • Article
  • Open Access
3 Citations
2,343 Views
13 Pages

Development of a Recombinant Fusion Vaccine Candidate Against Lethal Clostridium botulinum Neurotoxin Types A and B

  • Eun-Sun Choi,
  • Seong-Wook Pyo,
  • So-Hyeon Kim,
  • Jun-Ho Jeon,
  • Gi-Eun Rhie,
  • Mi-Ran Yun,
  • Hwajung Yi and
  • Yoon-Seok Chung

6 January 2025

Background: Botulinum neurotoxins (BoNTs), produced by Clostridium botulinum, are potent protein toxins that can cause botulism, which leads to death or neuroparalysis in humans by targeting the nervous system. BoNTs comprise three functional domains...

  • Article
  • Open Access
8 Citations
6,354 Views
11 Pages

Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain

  • Kyle S. Gregory,
  • Tejaswini B. Mahadeva,
  • Sai Man Liu and
  • K. Ravi Acharya

19 May 2022

Botulinum neurotoxins (BoNT) are a group of clostridial toxins that cause the potentially fatal neuroparalytic disease botulism. Although highly toxic, BoNTs are utilized as therapeutics to treat a range of neuromuscular conditions. Several serotypes...

  • Review
  • Open Access
17 Citations
12,784 Views
14 Pages

2 January 2018

Botulinum toxin (BTX) is a neurotoxin, and its injection in masticatory muscles induces muscle weakness and paralysis. This paralytic effect of BTX induces growth retardation of the maxillofacial bones, changes in dental eruption and occlusion state,...

  • Article
  • Open Access
7 Citations
4,203 Views
12 Pages

Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E

  • Geoffrey Masuyer,
  • Jonathan R. Davies and
  • Pål Stenmark

The botulinum neurotoxins are potent molecules that are not only responsible for the lethal paralytic disease botulism, but have also been harnessed for therapeutic uses in the treatment of an increasing number of chronic neurological and neuromuscul...

  • Article
  • Open Access
22 Citations
4,976 Views
10 Pages

4 January 2021

There are still concerns about masseteric bulging due to a lack of knowledge about the internal architecture of the masseter muscle. Further investigations are therefore required of the most-effective botulinum neurotoxin (BoNT) injection points and...

  • Article
  • Open Access
26 Citations
8,929 Views
15 Pages

Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction

  • Elisa Duregotti,
  • Giulia Zanetti,
  • Michele Scorzeto,
  • Aram Megighian,
  • Cesare Montecucco,
  • Marco Pirazzini and
  • Michela Rigoni

8 December 2015

Botulinum neurotoxins (BoNTs) and some animal neurotoxins (β-Bungarotoxin, β-Btx, from elapid snakes and α-Latrotoxin, α-Ltx, from black widow spiders) are pre-synaptic neurotoxins that paralyse motor axon terminals with similar clinical outcomes in...

  • Article
  • Open Access
6 Citations
4,623 Views
13 Pages

17 September 2020

Botulinum neurotoxins (BoNTs) can be used therapeutically to treat a wide range of neuromuscular and neurological conditions. A collection of natural BoNT variants exists which can be classified into serologically distinct serotypes (BoNT/B), and fur...

  • Review
  • Open Access
76 Citations
9,136 Views
11 Pages

Central Effects of Botulinum Neurotoxin—Evidence from Human Studies

  • David Weise,
  • Christopher M. Weise and
  • Markus Naumann

6 January 2019

For more than three decades, Botulinum neurotoxin (BoNT) has been used to treat a variety of clinical conditions such as spastic or dystonic disorders by inducing a temporary paralysis of the injected muscle as the desired clinical effect. BoNT is kn...

  • Article
  • Open Access
21 Citations
3,061 Views
8 Pages

9 April 2021

Breast reconstruction after mastectomy is commonly performed using transverse rectus abdominis myocutaneous (TRAM) flap. Previous studies have demonstrated that botulinum neurotoxin injections in TRAM flap surgeries lower the risk of necrosis and all...

  • Article
  • Open Access
21 Citations
10,585 Views
18 Pages

Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H

  • Gavin Hackett,
  • Kevin Moore,
  • David Burgin,
  • Fraser Hornby,
  • Bryony Gray,
  • Mark Elliott,
  • Imran Mir and
  • Matthew Beard

11 May 2018

We have purified and characterized recombinant botulinum neurotoxin serotype FA (BoNT/FA). This protein has also been named as a new serotype (serotype H), but the classification has been controversial. A lack of well-characterized, highly pure mater...

  • Article
  • Open Access
4 Citations
6,914 Views
14 Pages

Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E

  • Candace S. Bever,
  • Miles Scotcher,
  • Luisa W. Cheng,
  • Robert M. Hnasko and
  • Larry H. Stanker

13 July 2019

Botulism is a devastating disease caused by botulinum neurotoxins (BoNTs) secreted primarily by Clostridium botulinum. Mouse bioassays without co-inoculation with antibodies are the standard method for the detection of BoNTs, but are not capable of d...

  • Article
  • Open Access
6 Citations
3,325 Views
14 Pages

Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A

  • Shin-Ichiro Miyashita,
  • Shura Karatsu,
  • Mako Fujiishi,
  • I Hsun Huang,
  • Yuki Nagashima,
  • Tamaki Morobishi,
  • Keita Hosoya,
  • Tsuyoshi Hata,
  • Min Dong and
  • Yoshimasa Sagane

3 February 2023

Botulinum neurotoxin (BoNT), produced by Clostridium botulinum, cleaves proteins involved in neurotransmitter release, thereby triggering flaccid paralyses, which are responsible for botulism. BoNT is classified into seven serotypes (BoNT/A-G); BoNT/...

  • Article
  • Open Access
30 Citations
10,488 Views
24 Pages

Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples

  • Stéphanie Simon,
  • Uwe Fiebig,
  • Yvonne Liu,
  • Rob Tierney,
  • Julie Dano,
  • Sylvia Worbs,
  • Tanja Endermann,
  • Marie-Claire Nevers,
  • Hervé Volland and
  • Dorothea Sesardic
  • + 1 author

26 November 2015

Botulinum neurotoxins (BoNTs) cause the life-threatening neurological illness botulism in humans and animals and are divided into seven serotypes (BoNT/A–G), of which serotypes A, B, E, and F cause the disease in humans. BoNTs are classified as “cate...

  • Article
  • Open Access
6 Citations
4,668 Views
15 Pages

New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency

  • David Burgin,
  • Cindy Périer,
  • Gavin Hackett,
  • Mark Elliott,
  • Daniel Kwan,
  • Fraser Hornby,
  • Imran Mir,
  • Jacquie Maignel,
  • Sai Man Liu and
  • Matthew Beard

24 November 2021

Botulinum neurotoxins (BoNTs) are notorious toxins and powerful agents and can be lethal, causing botulism, but they are also widely used as therapeutics, particularly to treat neuromuscular disorders. As of today, the commercial BoNT treatments avai...

  • Feature Paper
  • Article
  • Open Access
22 Citations
7,231 Views
9 Pages

Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera

  • Lmar Babrak,
  • Alice Lin,
  • Larry H. Stanker,
  • Jeffery McGarvey and
  • Robert Hnasko

4 January 2016

Potent Botulinum neurotoxins (BoNTs) represent a threat to public health and safety. Botulism is a disease caused by BoNT intoxication that results in muscle paralysis that can be fatal. Sensitive assays capable of detecting BoNTs from different subs...

  • Article
  • Open Access
34 Citations
17,715 Views
18 Pages

17 January 2019

Lingual dystonia is a debilitating type of oromandibular dystonia characterized by involuntary, often task-specific, contractions of the tongue muscle activated by speaking or eating. Botulinum neurotoxin (BoNT) has been used to treat lingual dystoni...

  • Article
  • Open Access
11 Citations
2,888 Views
14 Pages

Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E

  • Zhen Li,
  • Jiansheng Lu,
  • Xiao Tan,
  • Rong Wang,
  • Qing Xu,
  • Yunzhou Yu and
  • Zhixin Yang

11 February 2022

Clostridium botulinum produces botulinum neurotoxin (BoNT), which is the most toxic known protein and the causative agent of human botulism. BoNTs have similar structures and functions, comprising three functional domains: catalytic domain (L), trans...

  • Review
  • Open Access
25 Citations
9,940 Views
18 Pages

20 October 2018

Botulinum neurotoxins (BoNTs) are categorised into immunologically distinct serotypes BoNT/A to /G). Each serotype can also be further divided into subtypes based on differences in amino acid sequence. BoNTs are ~150 kDa proteins comprised of three m...

  • Review
  • Open Access
19 Citations
5,806 Views
16 Pages

25 January 2021

For well over 30 years, the botulinum neurotoxin (BoNT) has been used for a large number of indications, some of which however have not been licensed. Admittedly, approval varies in many countries and this permits a large spectrum for evaluation. Thu...

  • Article
  • Open Access
16 Citations
8,750 Views
11 Pages

6 August 2013

Botulinum neurotoxins are one of the most potent toxins known to man. Current methods of detection involve the quantification of the toxin but do not take into account the percentage of the toxin that is active. At present the assay used for monitori...

  • Article
  • Open Access
5 Citations
6,332 Views
12 Pages

Content/Potency Assessment of Botulinum Neurotoxin Type-A by Validated Liquid Chromatography Methods and Bioassays

  • Bruna Xavier,
  • Rafaela Ferreira Perobelli,
  • Maurício Elesbão Walter,
  • Francielle Santos da Silva and
  • Sérgio Luiz Dalmora

12 January 2019

Botulinum neurotoxin type-A (BoNTA) is one of the seven different serotypes (A to G) produced by Clostridium botulinum. A stability-indicating size-exclusion chromatography (SEC) method was developed and validated, and the specificity was confirmed b...

  • Article
  • Open Access
10 Citations
8,868 Views
17 Pages

Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1

  • Jean Mukherjee,
  • Chase McCann,
  • Kwasi Ofori,
  • Julia Hill,
  • Karen Baldwin,
  • Charles B. Shoemaker,
  • Peter Harrison and
  • Saul Tzipori

19 December 2012

Botulinum neurotoxin (BoNT) is responsible for causing botulism, a potentially fatal disease characterized by paralysis of skeletal muscle. Existing specific treatments include polyclonal antisera derived from immunized humans or horses. Both prepara...

  • Article
  • Open Access
5 Citations
2,778 Views
15 Pages

Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane

  • Alexander Gardner,
  • William H. Tepp,
  • Marite Bradshaw,
  • Joseph T. Barbieri and
  • Sabine Pellett

15 October 2021

Botulinum neurotoxin serotype A (BoNT/A) is the most potent protein toxin to humans. BoNT/A light chain (LC/A) cleavage of the membrane-bound SNAP-25 has been well-characterized, but how LC/A traffics to the plasma membrane to target SNAP-25 is unkno...

  • Article
  • Open Access
33 Citations
3,891 Views
18 Pages

An Integrated Pharmacophore/Docking/3D-QSAR Approach to Screening a Large Library of Products in Search of Future Botulinum Neurotoxin A Inhibitors

  • Davide Gentile,
  • Giuseppe Floresta,
  • Vincenzo Patamia,
  • Rita Chiaramonte,
  • Giulia Letizia Mauro,
  • Antonio Rescifina and
  • Michele Vecchio

12 December 2020

Botulinum toxins are neurotoxins produced by Clostridium botulinum. This toxin can be lethal for humans as a cause of botulism; however, in small doses, the same toxin is used to treat different conditions. Even if the therapeutic doses are effective...

  • Article
  • Open Access
24 Citations
6,389 Views
19 Pages

Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B

  • Yongfeng Fan,
  • Jianbo Dong,
  • Jianlong Lou,
  • Weihua Wen,
  • Fraser Conrad,
  • Isin N. Geren,
  • Consuelo Garcia-Rodriguez,
  • Theresa J. Smith,
  • Leonard A. Smith and
  • Mengfei Ho
  • + 3 authors

26 August 2015

Existing antibodies (Abs) used to treat botulism cannot enter the cytosol of neurons and bind to botulinum neurotoxin (BoNT) at its site of action, and thus cannot reverse paralysis. However, Abs targeting the proteolytic domain of the toxin could in...

  • Article
  • Open Access
2 Citations
2,568 Views
13 Pages

1 October 2022

Scoliosis refers to a three-dimensional deviation in the axis of the spine. Muscle imbalance is believed to play a role in scoliosis. Botulinum neurotoxin (BoNT) can reduce muscle overactivity and may have the potential to ameliorate spinal scoliosis...

  • Review
  • Open Access
20 Citations
4,758 Views
11 Pages

A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change

  • Ren-Wen Ho,
  • Po-Chiung Fang,
  • Cheng-Hsien Chang,
  • Yu-Peng Liu and
  • Ming-Tse Kuo

24 January 2019

Clinical usage of botulinum neurotoxin (BoNT) in ophthalmology has dramatically increased since the 1980s and has become one of the most widely used agents for treating facial movement disorders, autonomic dysfunction and aesthetic wrinkles. Despite...

  • Review
  • Open Access
13 Citations
8,850 Views
22 Pages

18 January 2023

Botulinum neurotoxins (BoNTs) cause flaccid neuromuscular paralysis by cleaving one of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex proteins. BoNTs display high affinity and specificity for neuromuscular j...

  • Article
  • Open Access
14 Citations
5,881 Views
10 Pages

Docking Simulation and Sandwich Assay for Aptamer-Based Botulinum Neurotoxin Type C Detection

  • In-Hwan Oh,
  • Dae-Young Park,
  • Ji-Man Cha,
  • Woo-Ri Shin,
  • Ji Hun Kim,
  • Sun Chang Kim,
  • Byung-Kwan Cho,
  • Ji-Young Ahn and
  • Yang-Hoon Kim

12 August 2020

Aptamers are biomaterials that bind to a target molecule through a unique structure, and have high applicability in the diagnostic and medical fields. To effectively utilize aptamers, it is important to analyze the structure of the aptamer binding to...

of 10